ZBH | tickerfilter.com

Fundamental analysis

43%

Profitability 35%

Dept financing 50%

Liquidity 19%

Performance 56%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-0.48%

1 Month

11.22%

3 Months

5.16%

6 Months

-6.48%

1 Year

-5.79%

2 Year

-21.94%

Key data

Stock price

$97.97

P/E Ratio

25.27

DAY RANGE

$96.26 - $98.63

EPS

$3.56

52 WEEK RANGE

$84.59 - $114.44

52 WEEK CHANGE

-$6.47

MARKET CAP

17.820 B

YIELD

1.07%

SHARES OUTSTANDING

195.652 M

DIVIDEND

$0.24

EX-DIVIDEND DATE

03-31-2026

NEXT EARNINGS DATE

08-06-2025

BETA

0.45

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,818,865

AVERAGE 30 VOLUME

$2,365,196

Company detail

CEO: Bryan C. Hanson
Region: US
Website: zimmerbiomet.com
Employees: 18,000
IPO year: 2001

Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Zimmer Biomet Holdings, Inc. operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products.

ZBH - ZIMMER BIOMET HOLDINGS, INC.